The Joint Action on Personalised Cancer Medicine (JA PCM) is structured into 9 Pilots. JA PCM brings together expertise from 146 organisations across 29 countries to carry out coordinated activities under three thematic "Arms" (Prevention, Medicine, and Follow-up) and several cross-cutting areas. Each WP is led or co-led by national authorities or expert institutions and contributes to achieving the JA’s overarching goals.
Explore the pilots
Arm 1 - Personalised prevention and early detection
- Pilot 1 - Continuous data collection in a federated data-sharing platform
Creating a European network of molecular tumour boards to support treatment decisions for rare or complex cancer cases, including paediatrics.
Arm 2 - Personalised medicine
Arm 3 - Personalised follow-up and tertiary prevention
- Pilot 7 - Digital tools for remote monitoring, needs assessment, self-management advice and supportive care strategies
Applying liquid biopsy techniques in different clinical contexts including screening, treatment monitoring, and recurrence surveillance.